Trospium chloride: the European experience.


The primary pharmacological therapy for overactive bladder syndrome is muscarinic receptor antagonists. Muscarinic receptor blockade is effective in decreasing the symptoms of urinary urgency and urgency incontinence, but can be associated with troublesome complications, such as dry mouth, blurred vision, constipation and CNS side effects. Trospium chloride… (More)


Cite this paper

@article{Madersbacher2006TrospiumCT, title={Trospium chloride: the European experience.}, author={Helmut G Madersbacher and Eric S. Rovner}, journal={Expert opinion on pharmacotherapy}, year={2006}, volume={7 10}, pages={1373-80} }